Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-02 12:31 pm Sale | 13D | ALLAKOS INC ALLK | RiverVest Venture Fund III L.P. | 108,159 0.2% | -4,848,743 (-97.82%) | View |
| 2023-05-30 4:52 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | RiverVest Venture Fund III L.P. | 2,534,220 7.53% | 125,000 (+5.19%) | View |
| 2023-05-30 4:48 pm Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | RiverVest Venture Fund III L.P. | 3,527,281 8.6% | 1,379,000 (+64.19%) | View |
| 2021-04-19 2:04 pm Purchase | 13D | RENEO PHARMACEUTICALS INC RPHM | RiverVest Venture Fund III L.P. | 2,409,220 10% | 2,409,220 (New Position) | View |
| 2021-02-19 7:13 pm Sale | 13D | ALLAKOS INC ALLK | RiverVest Venture Fund III L.P. | 4,956,902 9.4% | -28,569 (-0.57%) | View |
| 2021-01-08 5:10 pm Sale | 13D | ALLAKOS INC ALLK | RiverVest Venture Fund III L.P. | 4,985,471 9.5% | -806,101 (-13.92%) | View |
| 2020-10-23 09:27 am Purchase | 13D | SPRUCE BIOSCIENCES INC SPRB | RiverVest Venture Fund III L.P. | 2,148,281 9.3% | 2,148,281 (New Position) | View |
| 2020-05-22 5:56 pm Sale | 13D | ALLAKOS INC ALLK | RiverVest Venture Fund III L.P. | 5,791,572 11.9% | -1,582,813 (-21.46%) | View |